Page last updated: 2024-11-05

tranexamic acid and Squamous Cell Carcinoma of Head and Neck

tranexamic acid has been researched along with Squamous Cell Carcinoma of Head and Neck in 1 studies

Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.

Squamous Cell Carcinoma of Head and Neck: The most common type of head and neck carcinoma that originates from cells on the surface of the NASAL CAVITY; MOUTH; PARANASAL SINUSES, SALIVARY GLANDS, and LARYNX. Mutations in TNFRSF10B, PTEN, and ING1 genes are associated with this cancer.

Research Excerpts

ExcerptRelevanceReference
"None of the patients experienced further bleeding following the commencement of tranexamic acid treatment, and no adverse effect was noted."4.89Treatment of bleeding upper aerodigestive tract tumor-a novel approach with antifibrinolytic agent: case series and literature review. ( Clark, JR; Elliott, M; Huang, J; Low, TH; Reid, C, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Low, TH1
Huang, J1
Reid, C1
Elliott, M1
Clark, JR1

Reviews

1 review available for tranexamic acid and Squamous Cell Carcinoma of Head and Neck

ArticleYear
Treatment of bleeding upper aerodigestive tract tumor-a novel approach with antifibrinolytic agent: case series and literature review.
    The Laryngoscope, 2013, Volume: 123, Issue:10

    Topics: Administration, Oral; Aged; Aged, 80 and over; Antifibrinolytic Agents; Carcinoma, Squamous Cell; Ep

2013